Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Gastrointestinal Cancer, Metastatic”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Early research (Phase 1)Study completedNCT05440942
What this trial is testing

Combined MEK, STAT3 and PD-1 Inhibition in Metastatic Pancreatic Ductal Adenocarcinoma

Who this might be right for
Pancreatic Ductal Adenocarcinoma
Peter Hosein, MD 28
Large-scale testing (Phase 3)Not Yet RecruitingNCT06616259
What this trial is testing

First-line Treatment of MCapOX + Cetuximab Vs. MFOLFOX6 + Cetuximab for RAS/BRAF Wild-type, MSS, Unresectable Left-Sided MCRC: a Multicenter, Randomized, Controlled, Phase III Study

Who this might be right for
Colorectal Cancer (CRC)CapecitabineCetuximab
Meng Qiu 452
Early research (Phase 1)Study completedNCT02155088
What this trial is testing

BYL719 in Combination With Gemcitabine and (Nab)-Paclitaxel in Locally Advanced and Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
H. Lee Moffitt Cancer Center and Research Institute 15
Large-scale testing (Phase 3)Ended earlyNCT01627379
What this trial is testing

Cisplatin and 5-FU +/- Panitumumab for Patients With Nonresectable,Advanced or Metastatic Esophageal Squamous Cell Cancer

Who this might be right for
Esophageal Squamous Cell Cancer
AIO-Studien-gGmbH 300
Testing effectiveness (Phase 2)Study completedNCT00967603
What this trial is testing

Maintenance Therapy With Sunitinib or Observation in Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
IRCCS San Raffaele 56
Not applicableStudy completedNCT03461341
What this trial is testing

European iNvestigation of SUrveillance After Resection for Esophageal Cancer

Who this might be right for
Esophageal CancerMetastatic CancerRecurrent Esophageal Cancer+4 more
St. James's Hospital, Ireland 3,000
Not applicableUnknownNCT04984096
What this trial is testing

Anlotinib Combined With PD-1 Inhibitors for Advanced/Metastatic Esophageal Cancer

Who this might be right for
Esophageal Cancer
Shanghai Chest Hospital 50
Testing effectiveness (Phase 2)Study completedNCT02074046
What this trial is testing

Safety Study of Cancer Stem Cell Vaccine to Treat Pancreatic Cancer

Who this might be right for
Neoplasms, Pancreas
Fuda Cancer Hospital, Guangzhou 40
Early research (Phase 1)Looking for participantsNCT06066138
What this trial is testing

Therapeutic Drug Monitoring-Based Atezolizumab Dosing

Who this might be right for
Locally Advanced Alveolar Soft Part SarcomaMetastatic Alveolar Soft Part SarcomaLocally Advanced Non Small Cell Lung Cancer+7 more
National Cancer Institute (NCI) 30
Early research (Phase 1)Study completedNCT00497497
What this trial is testing

PRO95780 in Combination With Cetuximab and Irinotecan Chemotherapy or the FOLFIRI Regimen With Bevacizumab in Patients With Previously Treated Metastatic Colorectal Cancer (APM4187g)

Who this might be right for
Colorectal Cancer
Genentech, Inc. 20
Testing effectiveness (Phase 2)Study completedNCT00636610
What this trial is testing

Vismodegib (GDC-0449, Hedgehog Pathway Inhibitor) With Concurrent Chemotherapy and Bevacizumab As First-Line Therapy for Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Genentech, Inc. 199
Not applicableStudy completedNCT00899210
What this trial is testing

Matrix Metalloproteinases After Surgery and/or Radiofrequency Ablation in Patients With Liver Metastases From Colorectal Cancer

Who this might be right for
Colorectal CancerMetastatic Cancer
University Hospital, Grenoble 75
Testing effectiveness (Phase 2)Study completedNCT00191984
What this trial is testing

The Combination of Pemetrexed and Irinotecan Every Two Weeks in Metastatic Colorectal Cancer

Who this might be right for
Metastatic Colorectal Cancer
Eli Lilly and Company 46
Post-approval studies (Phase 4)Study completedNCT03564938
What this trial is testing

Regorafenib in Indian Patients With Metastatic Colorectal Cancer (mCRC).

Who this might be right for
Metastatic Colorectal Cancer
Bayer 100
Testing effectiveness (Phase 2)Ended earlyNCT00019747
What this trial is testing

Surgery With or Without Thalidomide in Treating Patients With Recurrent or Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
National Institutes of Health Clinical Center (CC) 39
Testing effectiveness (Phase 2)Looking for participantsNCT04689347
What this trial is testing

5FU/LV, Irinotecan, Temozolomide and Bevacizumab for MGMT Silenced, Microsatellite Stable Metastatic Colorectal Cancer.

Who this might be right for
Metastatic Colorectal Cancer
Fondazione IRCCS Istituto Nazionale dei Tumori, Milano 27
Large-scale testing (Phase 3)UnknownNCT02024438
What this trial is testing

Monosialotetrahexosylganglioside Sodium Injection for Prevention Neurotoxicity of mFOLFOX 6 in Advanced Gastric Cancer

Who this might be right for
Gastric Cancer
Tianjin Medical University Cancer Institute and Hospital 240
Testing effectiveness (Phase 2)UnknownNCT03271255
What this trial is testing

Apatinib Versus Bevacizumab in Second-line Therapy for Colorectal Cancer(ABST-C)

Who this might be right for
Colorectal NeoplasmsIntestinal NeoplasmsGastrointestinal Neoplasms+1 more
Shenzhen People's Hospital 80
Early research (Phase 1)Looking for participantsNCT05285358
What this trial is testing

Pressurized Intraperitoneal Aerosolized Nab-Paclitaxel in Combination With Gemcitabine and Cisplatin for the Treatment of Biliary Tract Cancer Patients With Peritoneal Metastases

Who this might be right for
Distal Bile Duct AdenocarcinomaGallbladder CarcinomaIntrahepatic Cholangiocarcinoma+5 more
City of Hope Medical Center 12
Testing effectiveness (Phase 2)UnknownNCT00995358
What this trial is testing

A Study With Peptide Vaccination in Treating Patients With Esophageal Cancer

Who this might be right for
Esophageal Cancer
University of Yamanashi 60
Next Page